Skip to content

Clinical trials

Genetic Diseases, Inborn trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Not applicable Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20122
20142
20152
20162
20173
20184
20191
20204
20212
20223
20234
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting9
Recruiting4
Unknown status3
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rady Pediatric Genomics & Systems Medicine Institute5
Fairview University Medical Center3
Abramson Cancer Center at Penn Medicine2
Boston Children's Hospital2
Brigham and Women's Hospital2
Grand Valley State University2
Massachusetts General Hospital2
University of North Carolina, Chapel Hill2
Vanderbilt University Medical Center2
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn45
Rare Diseases10
Hematologic Diseases7
Genetic Predisposition to Disease6
Anemia, Sickle Cell5
Cardiovascular Diseases3
Cystic Fibrosis3
Disease3
Immune System Diseases3
Metabolism, Inborn Errors3

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.